TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 4.392
EU - Europa 2.325
AS - Asia 1.169
SA - Sud America 17
AF - Africa 9
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.924
Nazione #
US - Stati Uniti d'America 4.340
IT - Italia 494
IE - Irlanda 487
SG - Singapore 463
RU - Federazione Russa 434
HK - Hong Kong 356
SE - Svezia 332
DE - Germania 296
CN - Cina 197
GB - Regno Unito 83
CA - Canada 51
IN - India 41
UA - Ucraina 41
ID - Indonesia 28
VN - Vietnam 28
DK - Danimarca 26
BE - Belgio 23
FI - Finlandia 22
NL - Olanda 21
CZ - Repubblica Ceca 13
BR - Brasile 11
TR - Turchia 10
FR - Francia 9
KR - Corea 8
PL - Polonia 7
SA - Arabia Saudita 7
AU - Australia 6
ES - Italia 6
IR - Iran 6
PH - Filippine 6
EE - Estonia 4
HR - Croazia 4
JP - Giappone 4
MA - Marocco 4
MY - Malesia 4
NO - Norvegia 4
RS - Serbia 4
EG - Egitto 3
EU - Europa 3
GR - Grecia 3
LT - Lituania 3
TH - Thailandia 3
TW - Taiwan 3
BG - Bulgaria 2
CH - Svizzera 2
CO - Colombia 2
IL - Israele 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AT - Austria 1
CL - Cile 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
MN - Mongolia 1
NP - Nepal 1
RO - Romania 1
Totale 7.924
Città #
Ann Arbor 669
Dublin 474
Chandler 403
Singapore 399
Fairfield 387
Hong Kong 355
Ashburn 271
Frankfurt am Main 248
New York 238
Princeton 223
Houston 179
Woodbridge 175
Wilmington 168
Santa Clara 157
Seattle 148
Cambridge 119
Lawrence 107
Altamura 99
Milan 83
San Diego 44
Shanghai 42
Toronto 40
Jacksonville 37
Beijing 32
Jakarta 27
Andover 24
London 23
Brussels 22
Rome 22
Dearborn 19
Boardman 18
Nanjing 18
Chicago 15
Falls Church 13
Helsinki 13
Bergamo 12
Guangzhou 12
Los Angeles 12
Brno 10
Fuzhou 10
Pune 10
Washington 10
Dong Ket 8
Florence 8
Hangzhou 8
Munich 8
São Paulo 8
Brescia 7
Norwalk 7
Redmond 7
Shenzhen 7
Groningen 6
Kilburn 6
San Mateo 6
Villafranca Padovana 6
Amsterdam 5
Bari 5
Bologna 5
Chengdu 5
Lappeenranta 5
Mumbai 5
Riyadh 5
Wuhan 5
Belvedere Spinello 4
Canegrate 4
Changsha 4
Chennai 4
Deyang 4
Fremont 4
Hebei 4
Islington 4
Lachine 4
Oujda 4
Perugia 4
Poznan 4
Tallinn 4
Turin 4
Verano Brianza 4
Zagreb 4
Bangalore 3
Bivongi 3
Cairo 3
Capurso 3
Cassina de' Pecchi 3
Cernusco Sul Naviglio 3
Dongjak-gu 3
Edmonton 3
Esslingen am Neckar 3
Ferrara 3
Glasgow 3
Gunzenhausen 3
Hounslow 3
Jalandhar 3
Jinan 3
Kocaeli 3
Leicester 3
Montello 3
Monza 3
Naples 3
Oslo 3
Totale 5.646
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 257
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 230
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 178
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 170
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 146
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 141
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 130
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 129
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 118
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 116
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 115
Continuous subcutaneous insulin infusion in Italy: Third national survey 113
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 113
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 112
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 111
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 110
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 99
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 98
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 97
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 95
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 93
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 90
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 89
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 89
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 88
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 88
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 86
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 84
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 83
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 79
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 79
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 78
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 76
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 75
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 75
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 74
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 73
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 72
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 71
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 70
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 69
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 69
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 66
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 66
The Hyperfiltering Kidney in Diabetes 65
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 64
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 62
Lipids and renal disease 61
COMBINED "EN BLOC" LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS 59
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 57
The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction 55
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 55
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 55
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 55
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 55
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 55
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 55
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 54
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 52
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 52
Sodium-hydrogen antiporter: Its possible role in the genesis of diabetic nephropathy 52
Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control 52
Ronal and metabolic effects of insulin lispro in type 2 diabetic sublects with overt nephropathy 52
In situ Protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 51
Modulatory effect of insulin on release of calcium from human fibroblasts by angiotensin II 51
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial 51
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 50
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 50
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 50
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial 50
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 50
Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts 50
Diabetes and work: The need of a close collaboration between diabetologist and occupational physician 49
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 49
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 48
Treatment of diabetes in patients with kidney disease 48
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 48
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria 47
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial 47
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 47
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 46
Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes 46
PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates 46
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study 45
The decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes 44
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 43
Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme 42
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial 42
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 41
Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy 40
Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration 40
Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes 40
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 39
Preventing microalbuminuria in type 2 diabetes 38
Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes 37
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population 37
The effect of Mindfulness therapy in acromegaly, a pilot study 35
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 35
Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy 35
Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity 35
Totale 7.269
Categoria #
all - tutte 49.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.758


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020357 0 0 0 0 16 21 21 95 98 51 35 20
2020/20211.525 176 174 157 119 74 85 150 123 110 154 94 109
2021/20221.202 99 85 90 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.789 53 48 63 68 264 416 302 61 252 43 22 197
2024/20251.533 249 483 171 193 437 0 0 0 0 0 0 0
Totale 8.551